ESC 365 - Interleukin 1B gene polymorphism is associated with poor clinical outcomes in patients with coronary artery disease

ESC2025 Premium Access

Interleukin 1B gene polymorphism is associated with poor clinical outcomes in patients with coronary artery disease

Session: Immune modulation and inflammatory pathways in cardiovascular disease and myocarditis

Topic: Leukocytes, Inflammation, Immunity

Speaker: Doctor J. Li (Beijing, CN)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Jiawen Li

Beijing (China)

1 presentation

0 follower

6 more presentations in this session

Cardioprotective effect of genetic deletion of Atg5 gene or pharmacological autophagy inhibition in mouse model of experimental autoimmune myocarditis

Speaker: Mrs M. Czepiec (Cracow, PL)

Soluble ST2-associated protein induces cardiac injury by inhibiting mitochondrial ETC gene expression in cardiomyocytes in fulminant myocarditis

Speaker: Doctor Y. Zhuang (Wuhan, CN)

Large-scale and comprehensive analysis of the associations between immune cell traits and cardiovascular disease risks

Speaker: Doctor J. Ma (Beijing, CN)

Anti-inflammatory protection of early vs delayed sodium-glucose cotransporter-2 inhibitor therapy on monocyte-derived macrophages from patients with type2 diabetes with acute myocardial infarction.

Speaker: Miss J. Ward (Lincoln, GB)

The combination of ipragliflozin and losartan preserves cardiac function in a rat experimental autoimmune myocarditis model

Speaker: Doctor L. Kimena (Tsu, JP)

Access the full session

Immune modulation and inflammatory pathways in cardiovascular disease and myocarditis

Speakers: Doctor J. Li, Mrs M. Czepiec, Doctor Y. Zhuang, Doctor J. Ma, Miss J. Ward...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources